Michael T Rudd

Years Active: 2021-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Michael T Rudd, Peter J Manley, Barbara Hanney, Zhaoyang Meng, Youheng Shu, Pablo de Leon, Jessica L Frie, Yongxin Han, Jenny Miu-Chun Wai, Zhi-Qiang Yang, James J Perkins, Danielle M Hurzy, Jesse J Manikowski, Hong Zhu, Christopher J Bungard, Antonella Converso, Robert S Meissner, Mali L Cosden, Ikuo Hayashi, Lei Ma, Julie O'Brien, Victor N Uebele, Joel B Schachter, Neetesh Bhandari, Gwendolyn J Ward, Kerry L Fillgrove, Bing Lu, Yuexia Liang, David C Dubost, Vanita Puri, Donnie M Eddins, Joshua D Vardigan, Robert E Drolet, Jonathan T Kern, Jason M Uslaner
Discovery of MK-8768, a Potent and Selective mGluR2 Negative Allosteric Modulator. ACS medicinal chemistry letters 14 (8) (2023)
Chuan Hong, Noel J Byrne, Beata Zamlynny, Srivanya Tummala, Li Xiao, Jennifer M Shipman, Andrea T Partridge, Christina Minnick, Michael J Breslin, Michael T Rudd, Shawn J Stachel, Vanessa L Rada, Jeffrey C Kern, Kira A Armacost, Scott A Hollingsworth, Julie A O'Brien, Dawn L Hall, Terrence P McDonald, Corey Strickland, Alexei Brooun, Stephen M Soisson, Kaspar Hollenstein
Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation. Nature communications 12 (1) (2021)

Michael T Rudd.css-eqlu8i{font-size:small;padding-left:4px;}